Senior Director
Merck
Dr. Priscilla Velentgas is a Senior Director in the Vaccines Epidemiology group at Merck. Previously she was a Senior Director and Lead for Real World Safety Solutions and Global Scientific Head for Epidemiology at IQVIA, VP, Science for Aetion, and faculty member in the Harvard Medical School Department of Population Medicine.
Among her accomplishments, Dr. Velentgas is a co-developer of the GRACE checklist for observational CER study quality review, and was the senior editor of the 2013 Agency for Healthcare Research and Quality publication, "Developing a Protocol for Observational Comparative Effectiveness Research".
Dr. Velentgas received her MS and PhD in Epidemiology from the University of Washington School of Public Health and Community Medicine. She is based in Merck's Boston office and also works remotely from her home office in Maine.
Disclosure information not submitted.
Methods and New Approaches in Pragmatic Trials
Sunday, August 25, 2024
9:00 AM – 12:30 PM CEST